As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
Philips’ home ventilator recall is still in full force—spanning more than 18 months and over 5 million sleep apnea devices around the globe—and competitor ResMed has been looking to pick up the slack ...
Philips Respironics and ResMed have teamed up to introduce the new CPAP machine, a product for people who are unaware that their insomnia and sleepless nights may be a result of insufficient airflow.